03-Jul-2026 17:52:19
STARAcquisition and merger
STRIDES PHARMA SCIENCE LIMITED : ASCENT CAPITAL LED CONSORTIUM ACQUIRES MAJORITY STAKE IN PIVOT PATH
• The transaction for Strides' partnership with Ascent Capital for unlocking value in Pivot Path has been successfully completed. • Strides has sold its majority stake in Pivot Path to a consortium led by Ascent Capital and co-investor Vintage Classic. • The aggregate consideration for the transaction is approximately ₹1,000 million. • The company has received ₹750 million, with the balance ₹250 million payable on the first anniversary of the closing date. • Pivot Path has ceased to be a Wholly Owned Subsidiary of the Company effective July 1, 2026 and is now an Associate Company.
Strides Pharma Science Limited
Open attachment